(NASDAQ: MDRX) Veradigm's forecast annual revenue growth rate of -21.49% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 23.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.6%.
Veradigm's revenue in 2023 is $837,191,000.On average, 1 Wall Street analysts forecast MDRX's revenue for 2023 to be $71,816,450,765, with the lowest MDRX revenue forecast at $71,816,450,765, and the highest MDRX revenue forecast at $71,816,450,765.
In 2024, MDRX is forecast to generate $77,006,290,125 in revenue, with the lowest revenue forecast at $77,006,290,125 and the highest revenue forecast at $77,006,290,125.